PL145105B1 - Method of obtaining novel concentrated two-ring derivatives of imidazole - Google Patents

Method of obtaining novel concentrated two-ring derivatives of imidazole Download PDF

Info

Publication number
PL145105B1
PL145105B1 PL1985259307A PL25930785A PL145105B1 PL 145105 B1 PL145105 B1 PL 145105B1 PL 1985259307 A PL1985259307 A PL 1985259307A PL 25930785 A PL25930785 A PL 25930785A PL 145105 B1 PL145105 B1 PL 145105B1
Authority
PL
Poland
Prior art keywords
compounds
solution
alkyl
imidazole
tetrahydroimidazo
Prior art date
Application number
PL1985259307A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL145105B1 publication Critical patent/PL145105B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL1985259307A 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole PL145105B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/622,421 US4617307A (en) 1984-06-20 1984-06-20 Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors

Publications (1)

Publication Number Publication Date
PL145105B1 true PL145105B1 (en) 1988-08-31

Family

ID=24494112

Family Applications (6)

Application Number Title Priority Date Filing Date
PL1985259307A PL145105B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259305A PL145814B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed derivatives of double-ring imidazole
PL1985259306A PL145104B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985254099A PL145087B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel derivatives of imidazo /1,5-a/ pyridine
PL1985259303A PL145103B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259304A PL145348B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed disubstituted imidazole derivatives

Family Applications After (5)

Application Number Title Priority Date Filing Date
PL1985259305A PL145814B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed derivatives of double-ring imidazole
PL1985259306A PL145104B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985254099A PL145087B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel derivatives of imidazo /1,5-a/ pyridine
PL1985259303A PL145103B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259304A PL145348B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed disubstituted imidazole derivatives

Country Status (31)

Country Link
US (1) US4617307A (forum.php)
EP (1) EP0165904B1 (forum.php)
JP (1) JPS6112688A (forum.php)
KR (1) KR900008566B1 (forum.php)
AT (1) ATE62415T1 (forum.php)
AU (1) AU589565B2 (forum.php)
BG (7) BG60262B2 (forum.php)
CA (1) CA1276633C (forum.php)
CS (1) CS268672B2 (forum.php)
CY (1) CY1750A (forum.php)
DD (1) DD237510A5 (forum.php)
DE (1) DE3582452D1 (forum.php)
DK (1) DK170302B1 (forum.php)
DZ (1) DZ799A1 (forum.php)
ES (6) ES8702406A1 (forum.php)
FI (1) FI80694C (forum.php)
GR (1) GR851487B (forum.php)
HK (1) HK23494A (forum.php)
HU (1) HU202529B (forum.php)
IE (1) IE58070B1 (forum.php)
IL (1) IL75546A (forum.php)
MA (1) MA20459A1 (forum.php)
MX (1) MX9203369A (forum.php)
NO (1) NO162467C (forum.php)
NZ (1) NZ212483A (forum.php)
PH (1) PH23390A (forum.php)
PL (6) PL145105B1 (forum.php)
PT (1) PT80661B (forum.php)
RO (1) RO92583A (forum.php)
SU (6) SU1433413A3 (forum.php)
ZA (1) ZA854615B (forum.php)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4889861A (en) * 1982-12-21 1989-12-26 Ciba-Geigy Corp. Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
US5428160A (en) * 1982-12-21 1995-06-27 Ciba-Geigy Corporation Substituted imidazo[5-a]pyridine derviatives and other substituted bicyclic derivatives
GB8510541D0 (en) * 1985-04-25 1985-05-30 Wyeth John & Brother Ltd Heterocyclic compounds
US5171858A (en) * 1985-06-05 1992-12-15 Schering A.G. Preparation of certain 5,6-dihydro-8-phenyl-imidazo[1,5-a]pyridines
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
GB8820730D0 (en) * 1988-09-02 1988-10-05 Erba Carlo Spa Substituted 5 6 7 8-tetrahydroimidazo/1.5-a/pyridines & process for their preparation
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
CA2066369A1 (en) * 1991-04-19 1992-10-20 Alex Elbrecht Control of sex differentiation in fish
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
JPH05176659A (ja) * 1991-04-26 1993-07-20 Merck & Co Inc 家禽における雌性表現型を転換するために抗ミュラー管ホルモンを単独またはアロマターゼ阻害剤と組合せて使用する方法
AU2356195A (en) * 1994-04-14 1995-11-10 Sepracor, Inc. Treating estrogen-dependent diseases with (-)-fadrozole
AU682947B2 (en) * 1994-05-27 1997-10-23 Mochida Pharmaceutical Co., Ltd. Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
DE4432106A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
WO2004012728A1 (en) * 2002-07-30 2004-02-12 Novartis Ag Combination of an aromatase inhibitor with a bisphosphonate
ATE335744T1 (de) * 2002-08-07 2006-09-15 Novartis Pharma Gmbh Organische verbindungen als mittel zur behandlung von aldosteronbedingten zuständen
JP2006508970A (ja) * 2002-11-18 2006-03-16 ノバルティス アクチエンゲゼルシャフト イミダゾ［１，５ａ］ピリジン誘導体およびアルデステロンにより仲介される疾患の処置方法
WO2005007627A1 (ja) * 2003-07-18 2005-01-27 Nihon Nohyaku Co., Ltd. フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
JP2007529459A (ja) 2004-03-17 2007-10-25 ノバルティス アクチエンゲゼルシャフト 治療に置けるレニン阻害剤の使用
BRPI0511621A (pt) * 2004-05-28 2008-01-02 Speedel Experimenta Ag compostos orgánicos
EP2261225A1 (en) * 2004-05-28 2010-12-15 Novartis AG Heterocyclic compounds and their use as aldosterone synthase inhibitors
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
EP1842543A1 (en) 2006-04-05 2007-10-10 Speedel Pharma AG Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
RU2008150752A (ru) * 2006-05-26 2010-07-10 Новартис АГ (CH) Ингибиторы альдостеронсинтазы и/или 11-гидроксилазы
KR101149274B1 (ko) 2006-07-20 2012-05-29 노파르티스 아게 Ｃετρ 억제제로서의 아미노-피페리딘 유도체
RU2009110442A (ru) * 2006-08-25 2010-09-27 Новартис АГ (CH) Конденсированные производные имидазола для лечения нарушений, опосредованных альдостеронсинтазой, и/или 11-бета-гидроксилазой, и/или ароматазой
EP2120938A4 (en) * 2006-12-20 2010-12-08 Merck Sharp & Dohme IMIDAZOPYRIDINE ANALOGUE AS CB2 RECEPTOR MODULATORS FOR THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES
CN101910150B (zh) 2007-11-05 2013-09-18 诺瓦提斯公司 作为cetp抑制剂、可用于治疗疾病如高脂血症或动脉硬化的4-苄基氨基-1-羧基酰基哌啶衍生物
CN101878199B (zh) 2007-12-03 2013-09-18 诺瓦提斯公司 用于治疗例如高血脂或动脉硬化疾病的作为cetp抑制剂的1，2-二取代的-4-苄基氨基-吡咯烷衍生物
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
CN103896796B (zh) 2009-05-28 2016-04-27 诺华股份有限公司 作为脑啡肽酶抑制剂的取代的氨基丙酸衍生物
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
TWI518073B (zh) 2011-06-14 2016-01-21 美國禮來大藥廠 醛固酮合成酶抑制劑
ES2683350T3 (es) 2011-07-08 2018-09-26 Novartis Ag Método para tratar la aterosclerosis en sujetos con alto nivel de triglicéridos
AU2013209952B2 (en) * 2012-01-17 2016-09-01 Recordati Ag New forms and salts of a dihydropyrrolo(1,2-c)imidazolyl aldosterone synthase or aromatase inhibitor
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
WO2014126979A1 (en) 2013-02-14 2014-08-21 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
AU2014293387B2 (en) 2013-07-25 2017-04-20 Novartis Ag Bioconjugates of synthetic apelin polypeptides
HK1218298A1 (zh) 2013-07-25 2017-02-10 Novartis Ag 用於治疗心力衰竭的环状多肽
SG11201704758XA (en) 2015-01-23 2017-08-30 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
MX2017009839A (es) * 2015-01-29 2017-11-02 Novartis Ag Proceso para la produccion de derivados de imidazolo condensados.
GB201511790D0 (en) * 2015-07-06 2015-08-19 Iomet Pharma Ltd Pharmaceutical compound
JP2016074729A (ja) * 2015-12-31 2016-05-12 国立大学法人 千葉大学 イミダゾリウム塩及びそれを用いた不斉合成触媒並びにイミダゾリウム塩の製造方法
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
CN114853755A (zh) * 2016-10-27 2022-08-05 达米安制药股份公司 醛固酮合酶抑制剂
WO2018078049A1 (en) 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
US11992479B2 (en) 2018-05-03 2024-05-28 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism
CN113166204B (zh) 2018-11-27 2025-01-28 诺华股份有限公司 作为治疗代谢障碍的蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型（PCSK9）抑制剂的环状肽
JP2022507958A (ja) 2018-11-27 2022-01-18 ノバルティス アーゲー 代謝障害の治療用のプロタンパク質転換酵素サブチリシン／ケキシン９型（ｐｃｓｋ９）阻害薬としての環状四量体化合物
UY38485A (es) 2018-11-27 2020-06-30 Novartis Ag Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
WO2023084449A1 (en) 2021-11-12 2023-05-19 Novartis Ag Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5124517B1 (forum.php) * 1971-03-15 1976-07-24
FR2449689A1 (fr) * 1979-02-20 1980-09-19 Logeais Labor Jacques Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
FI75569C (fi) * 1981-06-22 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av terapeutiskt verkande imidazo/1,5-a/pyridiner.
US4409226A (en) * 1981-10-05 1983-10-11 Schering Corporation Imidazo[1,5-a]pyridines
US4361567A (en) * 1981-10-05 1982-11-30 Schering Corporation Treatment of peptic ulcer disease
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
EP0165904B1 (de) 1991-04-10
PL254099A1 (en) 1986-09-09
SU1436878A3 (ru) 1988-11-07
ES8802049A1 (es) 1988-03-16
HUT37936A (en) 1986-03-28
FI852399L (fi) 1985-12-21
US4617307A (en) 1986-10-14
DD237510A5 (de) 1986-07-16
CY1750A (en) 1994-06-03
ZA854615B (en) 1986-02-26
ES555541A0 (es) 1987-11-16
ES8702406A1 (es) 1987-01-01
ES8802155A1 (es) 1988-04-01
MA20459A1 (fr) 1985-12-31
EP0165904A2 (de) 1985-12-27
ES555539A0 (es) 1988-04-01
GR851487B (forum.php) 1985-11-25
ES544344A0 (es) 1987-01-01
SU1443802A3 (ru) 1988-12-07
NZ212483A (en) 1988-10-28
PT80661B (en) 1987-05-04
JPH047746B2 (forum.php) 1992-02-12
PT80661A (en) 1985-07-01
EP0165904A3 (en) 1987-09-09
NO162467C (no) 1990-01-10
BG60402B2 (bg) 1995-02-28
HK23494A (en) 1994-03-25
DK277685D0 (da) 1985-06-19
BG60307B2 (en) 1994-07-25
ES555540A0 (es) 1987-12-16
PL145348B1 (en) 1988-09-30
PL145087B1 (en) 1988-08-31
IE851520L (en) 1985-12-20
ATE62415T1 (de) 1991-04-15
ES8801262A1 (es) 1987-12-16
ES555538A0 (es) 1988-03-16
IE58070B1 (en) 1993-06-30
FI852399A0 (fi) 1985-06-17
FI80694B (fi) 1990-03-30
PL145814B1 (en) 1988-11-30
DE3582452D1 (de) 1991-05-16
BG60262B1 (bg) 1994-03-31
JPS6112688A (ja) 1986-01-21
HU202529B (en) 1991-03-28
MX9203369A (es) 1992-09-01
CS268672B2 (en) 1990-04-11
FI80694C (fi) 1990-07-10
AU589565B2 (en) 1989-10-19
CA1276633C (en) 1990-11-20
SU1433413A3 (ru) 1988-10-23
BG60305B2 (bg) 1994-07-25
PL145104B1 (en) 1988-08-31
SU1436880A3 (ru) 1988-11-07
NO852474L (no) 1985-12-23
CS444985A2 (en) 1989-07-12
IL75546A0 (en) 1985-10-31
KR900008566B1 (ko) 1990-11-24
AU4385785A (en) 1986-01-02
BG60306B2 (bg) 1994-07-25
BG60262B2 (en) 1994-03-31
BG60352B2 (bg) 1994-11-30
ES8802048A1 (es) 1988-03-16
DK170302B1 (da) 1995-07-31
DK277685A (da) 1985-12-21
SU1436879A3 (ru) 1988-11-07
DZ799A1 (fr) 2004-09-13
IL75546A (en) 1990-01-18
KR860000299A (ko) 1986-01-27
NO162467B (no) 1989-09-25
ES8800681A1 (es) 1987-11-16
BG60353B2 (bg) 1994-11-30
ES555542A0 (es) 1988-03-16
SU1482530A3 (ru) 1989-05-23
PH23390A (en) 1989-07-26
PL145103B1 (en) 1988-08-31
RO92583A (ro) 1987-11-30

Similar Documents

Publication Publication Date Title
PL145105B1 (en) Method of obtaining novel concentrated two-ring derivatives of imidazole
US4355040A (en) Hypotensive imidazole-5-acetic acid derivatives
US4889861A (en) Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
US5015639A (en) Substituted benzazepines, their preparation and pharmaceutical compositions containing them
US5247080A (en) Substituted benzazepines useful as intermediates for producing pharmaceutically active compounds
PL152025B1 (en) Alpha-heterocycle substituted tolunitriles
EP0091241A2 (en) Condensed pyrrolinone derivatives, and their production
US5587392A (en) Azolyl methyl phenyl derivatives having aromatase inhibitory activity
US4916148A (en) Naphtho(2,1-b) furan derivatives
US4434171A (en) Dibenzazepine derivatives, pharmaceutical compositions containing them, and pharmaceutical methods using them
US4728645A (en) Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4771047A (en) Benzazepine derivatives
US4859691A (en) Certain 1,2-benzisoxazole derivatives
US5021445A (en) Compounds useful for the treatment of hypoglycemia
EP0229329A1 (en) Benzazepine derivatives
HU188475B (en) Process for producing benzothiopyrano-pyridinones
US5428160A (en) Substituted imidazo[5-a]pyridine derviatives and other substituted bicyclic derivatives
US4791115A (en) 2,6-dimethyl-8α-pivaloylamino-9,10-didehydro-ergoline
US5310750A (en) Heterocyclic compounds useful as α2 -adrenoceptor antagonists
JP2776984B2 (ja) 新規な縮合チアゾール誘導体，その製造法及びその医薬組成物
EP0090275B1 (en) Isoxazole (5,4-b) pyridines
US6054469A (en) Substituted tetrahydropyridine derivatives acting on 5-HT receptors
US4957931A (en) Certain 1,2-benzisoxazole and 1,2-benzisothiazole derivatives
US5374722A (en) Bridged benzazepines
PL174416B1 (pl) Nowe związki, pochodne fenylo-imidazolidynonu i sposób ich wytwarzania